Advertisement

RVP

Retractable Technologies, Inc.

Healthcare · USD

Set alert

Price alert · RVP

All alert types
0.57 USD -0.01 -1.96%
As of Oct 30, 2026 Extended hours 0.57 0.00%
Bid
0.56 × 400
Ask
0.60 × 100
0.565 Day range 0.5824
0.565 52-week range 0.88
YTD
-26.62%
1 year
-35.06%
Open
0.59
Prev close
0.5763
Mkt cap
16.91M
Vol
33.28K
Avg vol
30.39K
EPS
-0.12
P/E
0.00
Div yield
0.00%
More statistics
Low
0.565
High
0.5824
Forward P/E
0.00
Beta
2.06
Short ratio
0.67
Inst. own
8.07%
Dividend
0.00
Ex-div date
50-d avg
0.6776
200-d avg
0.95165
1y target
0.00

2Y chart

Chart tools
Interval
RVP two-year price chart0.560.710.850.991.14Oct 24Mar 25Aug 25Jan 26Jun 26Oct 26

Key statistics

Market cap
18.56M
Enterprise value
-21.87M
Trailing P/E
0.00
Forward P/E
0.00
PEG ratio
0.00
Price / sales
0.49
Price / book
0.19
EPS (TTM)
-0.53
Beta
2.06
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-46.71%
Revenue (TTM)
38.25M
Revenue growth
-24.40%
Free cash flow
7.40M
Total cash
41.90M
Total debt
1.39M
Return on equity
-18.91%
Shares outstanding
29.94M
Short % of float
0.24%
50-day average
0.6776
200-day average
0.95165

Analyst view

Consensus: none

Price target (mean) 0.00

Next earnings

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
RVP Revenue — quarterly 7.20M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
RVP Net income — quarterly 2.83M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
RVP EPS — quarterly 0.09
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

About Retractable Technologies, Inc.

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States

News

Your note

Sign in to keep a note on RVP — it syncs with the Stock Master app.

Insider holders

RVP insider holders
InsiderRelationLatest transactionDateShares held
LEONARD BRADEN MICHAELBeneficial Owner of more than 10% of a Class of SecuritySaleDec 28, 20220
SHAW THOMAS JChief Executive OfficerPurchaseDec 17, 202415,752,400

Institution ownership

RVP institution ownership
Holder% heldSharesValueReported
Vanguard Group Inc2.30%689,509427.50KSep 29, 2024
Renaissance Technologies, LLC1.10%330,113204.67KSep 29, 2024
Blackrock Inc.0.92%275,242170.65KSep 29, 2024
Bridgeway Capital Management, Inc.0.53%158,96498.56KSep 29, 2024
Geode Capital Management, LLC0.40%119,16673.88KSep 29, 2024
UBS Group AG0.36%106,77566.20KSep 29, 2024

Fund ownership

RVP fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund1.41%421,212261.15KSep 29, 2024
Vanguard Extended Market Index Fund0.82%246,784153.01KSep 29, 2024
Bridgeway Funds Inc-Ultra Small Company Market Fund0.24%71,70044.45KSep 29, 2024
Bridgeway Funds Inc-Ultra Small Company Fund0.22%66,43441.19KSep 29, 2024
Fidelity Extended Market Index Fund0.19%56,55135.06KOct 30, 2024
Fidelity Total Market Index Fund0.11%32,18719.95KOct 30, 2024
Advertisement